Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 923-900-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Version / remarks:
- (2001)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Esterification products of fatty acids, C16 and C16-18 (even numbered, unsaturated) alkyl and adipic acid with pentaerythritol
- EC Number:
- 923-900-3
- Molecular formula:
- Not applicable (UVCB substance)
- IUPAC Name:
- Esterification products of fatty acids, C16 and C16-18 (even numbered, unsaturated) alkyl and adipic acid with pentaerythritol
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Stability in vehicle analytically confirmed.
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Hsd Cpb:WU (SPF-bred)
- Source: Harlan-Netherlands B.V., Horst 5961 NM, Netherlands
- Age at study initiation: at least 12 weeks
- Weight at study initiation: 205 - 276 g (females)
- Housing: From gestation day 0 (= day 0 p.c.) animals were individually accommodated in Type IIIh Makrolon cages on low-dust wood shavings.
- Diet and water: ad libitum
- Acclimation period: at least seven days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.8 – 22.7
- Humidity (%): 54 - 67
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- paraffin oil
- Details on exposure:
- Administration volume: 2 mL/kg bw
PREPARATION OF DOSING SOLUTIONS: The formulations were prepared as needed taking into account the analytically determined stability.
VEHICLE
- Justification for use and choice of vehicle (if other than water): The test item in the vehicle gave a liquid formulation/ oily solution, for which stability for at least 8 days was given. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- For content check the concentrations of samples of control and each test item dosage form prepared were determined twice during the study.
For analysis a portion of the dosage form was filled into a sodium chloride cell. A high resolution FTIR spectrum was scanned and evaluated. Quantification is based upon the concentration-dependent absorption bands due to the oscillation of ester function bond which occurs near 1750/cm. - Details on mating procedure:
- The animals were mated by placing one female overnight into a Type IIIh cage together with one male rat. If sperm was detected in the vaginal smear taken on the morning following mating, this day was regarded as day 0 of gestation.
- Duration of treatment / exposure:
- Day 6 - 20 p. c.
- Frequency of treatment:
- once daily (between 06:00 and 12:00 CET)
- Duration of test:
- From study initiation date to end of in-life-phase 55 days.
- No. of animals per sex per dose:
- 25 females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: In an orientating embryotoxicity study in rats with the test substance 5 female rats received the limit dose of 1000 mg/kg bw orally once daily from day 6 to day 20 of gestation. Corn oil was used in this study as vehicle. In this orientating study no indications for maternotoxicity or fetotoxicity occurred. A further orientating study was conducted in 3 male and 3 female rats each which were treated once daily orally over a period of 2 weeks with 1000 mg/kg bw by using paraffin oil as vehicle (pilot study for oral repeated dose toxicity study). Again the limit dose was tolerated without obvious findings of toxicity.
Examinations
- Maternal examinations:
- CLINICAL EXAMINATIONS: Yes
- Time schedule: From day 0 to 21 p.c. all animals were inspected once daily, and all findings were recorded.
Attention was paid to disturbances in the general condition of the rats (appearance, behavior), and any alterations concerning their excretory products.
BODY WEIGHT: Yes
- Time schedule for examinations: The body weights of the animals were determined on day 0 p.c. and daily from days 6 to 21 p.c.
Additionally, corrected body weight was calculated by subtracting the weight of the uterus on day 21 p.c. from the body weight on day 21 p.c. Furthermore, corrected body weight change was calculated by subtracting the body weight of day 6 p.c. from the corrected body weight.
FOOD CONSUMPTION: Yes
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day.
WATER CONSUMPTION: No data - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Necropsies/cesarean sections were performed on gestation day 21.
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Number of dead and live fetuses: Yes
- Other: individual weight and appearance of the placentas - Fetal examinations:
- - sex of live fetuses
- individual weights of live fetuses
- External examinations: Yes, findings in alive and dead fetuses are included
- Soft tissue and head examinations: Yes, evaluation of about half of alive fetuses per litter, fetuses of one dam could not be evaluated due to fixation problems
- Skeletal and cartilage abnormalities: Yes, evaluation in about half of alive fetuses per litter - Statistics:
- Differences between the control and test item treated groups were considered to be significant when p < 0.05. Statistical evaluation was done by Dr. J. Fry, P.N. Lee Statistics and Computing Ltd., Sutton, Great Britain.
The following standard statistical tests were applied to the data in order to compare dose group values with the respective control group values: For the endpoints where Gaussian distribution was assumed, mean values and standard deviations were calculated and Dunnett-test was applied to the data in order to compare dose group values with the respective control group values. For the endpoints where binomial distribution was assumed, Bonferroni-Holm procedure with pairwise Fisher's Exact tests was used to compare dose group values with the respective control group values. For the endpoints for which no assumption about the distribution was made, group medians and quartiles were calculated and pairwise Wilcoxon Man Whitney tests were used to compare dose group values with the respective control group values. - Indices:
- gestation rate
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
No substance related finding was noted in maternal animals up to and including the high dose level of 1000 mg/kg bw.
The gestation rate, number of corpora lutea, postimplantation loss, litter size, number of fetuses, fetal sex distribution, placental weights and placental appearance were not affected by treatment up to and including 1000 mg/kg bw.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Remarks:
- Maternal toxicity
- Effect level:
- 1 000 mg/kg bw/day
- Basis for effect level:
- other: No substance-related findings noted in maternal animals up to and including 1000 mg/kg (highest dose tested)
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
No compound-related fetal structural findings classified as malformations or variations were observed in this study at levels up to and including 1000 mg/kg bw.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Remarks:
- Developmental toxicity
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
- Basis for effect level:
- other: No substance-related structural findings noted in fetuses up to and including 1000 mg/kg (highest dose tested)
Fetal abnormalities
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Developmental effects observed:
- no
Applicant's summary and conclusion
- Executive summary:
A developmental toxicity/teratogenicity study according to OECD TG 414 was conducted with twenty-five inseminated female Wistar rats each treated daily orally by gavage with the test substance using paraffin oil as vehicle. Females were treated from day 6 to day 20 of gestation with dosages of 0 (vehicle control), 100, 300 and 1000 mg/kg bw. The fetuses were delivered by cesarean section on day 21 of gestation.
No substance related findings were noted in maternal animals up to and including the high dose level of 1000 mg/kg bw. The gestation rate, number of corpora lutea, postimplantation loss, litter size, number of fetuses, fetal sex distribution, placental weights and placental appearance were not affected by treatment up to and including 1000 mg/kg bw test substance. No compound-related fetal structural findings classified as malformations or variations were observed in this study at levels up to and including 1000 mg/kg bw.
The no-observed-adverse-effect levels (NOAELs) were determined both for maternal and developmental toxicity to be 1000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.